Polymorphisms in a disintegrin and metalloprotease 33 gene and the risk of chronic obstructive pulmonary disease: A meta-analysis

Respirology

Volumn 19, Issue 3, 2014, Pages 312-320

  Zhang, Rui ^a   Li, He ^a   Zhao, Haiming ^a   Chen, Wangyue ^a   Cheng, Deyun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

a disintegrin and metalloprotease 33; chronic obstructive pulmonary disease; meta analysis; polymorphism; risk

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE 33 PROTEIN; ADAM PROTEIN; UNCLASSIFIED DRUG; ADAM33 PROTEIN, HUMAN; DISINTEGRIN;

CAUCASIAN; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CODOMINANCE; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE;

ADAM PROTEINS; DISINTEGRINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84896313892     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12235     Document Type: Review

References (33)

1. Global Initiative for Chronic Obstructive Lung Disease. February 2013. GOLD Workshop Report: global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2013). [Accessed 15 May 2013.] Available from URL: http://www.goldcopd.org/
2. van Diemen CC, Postma DS, Aulchenko YS, Snijders PJ, Oostra BA, van Duijn CM, Boezen HM,. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate. Eur. Respir. J. 2010; 35: 768-775.
3. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J,. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935-939.
4. McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA,. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am. J. Respir. Crit. Care Med. 2001; 164: 1419-1424.
5. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418: 426-430.
6. Gosman MM, Boezen HM, van Diemen CC, Snoeck-Stroband JB, Lapperre TS, Hiemstra PS, Ten Hacken NH, Stolk J, Postma DSA,. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 2007; 62: 242-247.
7. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM,. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am. J. Respir. Crit. Care Med. 2005; 172: 329-333.
8. Simpson A, Maniatis N, Jury F, Cakebread JA, Lowe LA, Holgate ST, Woodcock A, Ollier WE, Collins A, Custovic A, et al. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am. J. Respir. Crit. Care Med. 2005; 172: 55-60.
9. Jongepier H, Boezen HM, Dijkstra A, Howard TD, Vonk JM, Koppelman GH, Zheng SL, Meyers DA, Bleecker ER, Postma DS,. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin. Exp. Allergy 2004; 34: 757-760.
10. Kavvoura FK, Ioannidis JP,. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum. Genet. 2008; 123: 1-14.
11. Zhang Y, Zhang J, Huang J, Li X, He C, Tian C, Peng C, Guo L, Xiao Y, Fan H,. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: a meta-analysis. Respirology 2010; 15: 643-650.
12. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002; 21: 1539-1558.
13. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
14. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
15. Korytina GF, Tselousova OS, Akhmadishina LZ, Victorova EV, Zagidullin Sh Z, Victorova TV,. Association of MMP3, MMP9, ADAM33, and TIMP3 polymorphisms with chronic obstructive pulmonary disease and its progression. Mol. Biol. 2012; 46: 438-449.
16. Sadeghnejad A, Ohar JA, Zheng SL, Sterling DA, Hawkins GA, Meyers DA, Bleecker ER,. ADAM33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir. Res. 2009; 10: 21.
17. Pabst S, Pizarro Touron C, Gillissen A, Lennarz M, Tuleta I, Nickenig G, Skowasch D, Grohe C,. ADAM33 gene polymorphisms in chronic obstructive pulmonary disease. Eur. J. Med. Res. 2009; 14 (Suppl. 4): 182-186.
18. Xiao J, Han J, Wang X, Hua D, Su D, Bao Y, Lv F,. Association of ADAM33 gene with susceptibility to COPD in Tibetan population of China. Mol. Biol. Rep. 2011; 38: 4941-4945.
19. Wang X, Li L, Xiao J, Jin C, Huang K, Kang X, Wu X, Lv F,. Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population. BMC Med. Genet. 2009; 10: 132.
20. Qin RJ, Wang H, Guo CC, Ma YB, Yin HT, Li JQ, Wang P, Zhang KM,. Association between single nucleotide polymorphisms and haplotypes in ADAM33 gene and chronic obstructive pulmonary disease. Int. J. Respir. 2012; 32: 182-187 (in Chinese).
21. Chi LF, Wang P, Wang H, Shang XF, Qiao KH, Zheng SG, Yin HT,. Association of polymorphism of ADAM33 gene and chronic obstructive pulmonary disease. China Med. Herald 2013; 10: 15-17 (in Chinese).
22. Chi XY, Xiao W, Wang JP, Jiang HJ, Wang LC, Wang J,. Association between ADAM33 gene polymorphism and COPD. Shandong Med. J. 2011; 51: 1-3 (in Chinese).
23. Yin YQ, Wang AH, Chen P, Liu QJ, Yu QF,. Association between ADAM33 gene polymorphism and chronic obstructive pulmonary disease. Chin. J. Nosocomiol. 2010; 20: 1840-1843 (in Chinese).
24. Zhou JT, Sun YF,. The relationship between ADAM33 S2 site gene mutation and disease course and age of the patients with COPD. Chin. J. Clin. Ration. Drug Use 2012; 5: 1-2 (in Chinese).
25. Dijkstra A, Postma DS, Noordhoek JA, Lodewijk ME, Kauffman HF, ten Hacken NH, Timens W,. Expression of ADAMs ('a disintegrin and metalloprotease') in the human lung. Virchows Arch. 2009; 454: 441-449.
26. Schedel M, Depner M, Schoen C, Weiland SK, Vogelberg C, Niggemann B, Lau S, Illig T, Klopp N, Wahn U, et al. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respir. Res. 2006; 7: 91.
27. Lee YH, Song GG,. Association between ADAM33 T1 polymorphism and susceptibility to asthma in Asians. Inflamm. Res. 2012; 61: 1355-1362.
28. Li X, Zhang Y, Zhang J, Xiao Y, Huang J, Tian C, He C, Deng Y, Yang Y, Fan H,. Asthma susceptible genes in Chinese population: a meta-analysis. Respir. Res. 2010; 11: 129.
29. Liang S, Wei X, Gong C, Wei J, Chen Z, Deng J,. A disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms and the risk of asthma: a meta-analysis. Hum. Immunol. 2013; 74: 648-657.
30. Song GG, Kim JH, Lee YH,. Association between ADAM33 S2 and ST+4 polymorphisms and susceptibility to asthma: a meta-analysis. Gene 2013; 524: 72-78.
31. Aierken H, Wushouer Q, Shayhidin E, Jing W, Wufuer D,. Polymorphisms of the ADAM33 gene and chronic obstructive pulmonary disease risk: a meta-analysis. Clin. Respir. J. 2013. doi 10.1111/crj.12046.
32. Reijmerink NE, Kerkhof M, Koppelman GH, Gerritsen J, de Jongste JC, Smit HA, Brunekreef B, Postma DS,. Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness. Allergy 2009; 64: 898-904.
33. Bukvic BK, Blekic M, Simpson A, Marinho S, Curtin JA, Hankinson J, Aberle N, Custovic A,. Asthma severity, polymorphisms in 20p13 and their interaction with tobacco smoke exposure. Pediatr. Allergy Immunol. 2013; 24: 10-18.